Top Markets
Coin of the day
Vaxart, Inc. Vaxart, Inc.

Vaxart, Inc.

VXRT
Rang in Aktien #20724
Vaxart, Inc. operates as a biotechnology firm currently in the clinical... Vaxart, Inc. operates as a biotechnology firm currently in the clinical development phase, concentrating its efforts on identifying and advancing novel oral recombinant protein vaccines. The company leverages its unique proprietary platform for delivering these oral vaccine solutions. Its diverse pipeline showcases several promising candidates: An oral tablet vaccine targeting norovirus, which is presently undergoing Phase Ib clinical assessment for both GI.1 and GII.4 strains. A seasonal influenza vaccine, now in Phase II clinical studies, designed to address H1 influenza infections. A vaccine candidate against respiratory syncytial virus (RSV). A coronavirus vaccine, also advancing through Phase II clinical trials for SARS-CoV-2. Beyond infectious diseases, Vaxart is also engaged in formulating therapeutic vaccines aimed at treating cervical cancer and dysplasia associated with human papillomavirus. The company's main operations are situated in South San Francisco, California.
Aktienkurs
$0.5106
Marktkapitalisierung
$123.59M
Veränderung (1 Tag)
-1.81%
Veränderung (1 Jahr)
45.89%
Land
US
Handel Vaxart, Inc. (VXRT)

Kategorie

Aktien-Split-Historie für Vaxart, Inc. (VXRT)
Die Aktie Vaxart, Inc. (Symbol: VXRT) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 24, 2026 statt.
Eine VXRT-Aktie, die vor dem Aug 24, 2026 gekauft wurde, entspricht heute 0 VXRT-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH